Ocular surface disease among glaucoma patients in Ibadan, South-West Nigeria
DOI:
https://doi.org/10.64666/joecsa.2015.135Keywords:
Benzalkonium chloride, Glaucoma, Ibadan, Ocular surface diseaseAbstract
Objective: To study the frequency and severity of ocular surface disease among glaucoma patients attending the Eye Clinic of the University College Hospital, Ibadan, Nigeria.
Methods: A hospital-based, cross sectional study was carried out at the Eye Clinic of the University College Hospital, Ibadan. After a detailed ocular examination, each respondent completed an Ocular Surface Disease Index (OSDI) questionnaire and performed central visual field assessment. Participants were analyzed for theeffect of anti-glaucoma topical medications (all BAK-preserved) and glaucoma severity on ocular surface disease.
Results: A total of 122 consecutive glaucoma patients were studied. Males accounted for 45.1%. Increasing daily drops of anti-glaucoma medication was significantly associated with increasing side effects such as redness, stinging and peppery sensations (p < 0.01). Eighty four patients representing 68.9% had some form of OSD using the OSDI score. The OSDI scores and the number of patients with OSD significantly increased with increasing glaucoma severity (p < 0.01).
Conclusion: Ocular surface disease was found to be associated with glaucoma severity and use of BAK-preserved topical anti-glaucoma medications.
Downloads
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2026 Dr.Sarimiye T.F, Fasina O., Ashaye A., Bekibele C., Olawoye O.

This work is licensed under a Creative Commons Attribution 4.0 International License.
JOECSA publishes all content Open Access under the Creative Commons Attribution 4.0 International License (CC BY 4.0). Authors retain copyright. Anyone may share and adapt the work for any purpose, provided appropriate credit is given to the original author(s) and the source. License: https://creativecommons.org/licenses/by/4.0/
